• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Brain HDL Function Emerges as Key Factor in Alzheimer’s Disease Pathology

by
November 17, 2026
in Health
Reading Time: 2 mins read
0
Brain HDL Function Emerges as Key Factor in Alzheimer's Disease Pathology

Brain HDL Function Emerges as Key Factor in Alzheimer's Disease Pathology

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A scientific review published in Molecular Neurodegeneration examines the evolving understanding of high-density lipoproteins and brain-specific HDL-like particles, emphasizing an important paradigm shift from simply measuring circulating HDL levels to evaluating HDL function in Alzheimer’s disease.

High-density lipoproteins belong to a specialized class of lipid-protein complexes that are assembled within extracellular spaces and circulate as soluble nanoparticles through biological fluids. Throughout the body, these nanoparticles serve as critical transport vehicles, ferrying lipids and their associated molecules to and from cells across various physiological compartments. Although HDL represents the very first lipoprotein group ever discovered by scientists, it paradoxically remains the least understood member among all circulating lipoproteins.

However, research interest in HDL-like particles located within the brain expanded substantially following the identification of apolipoprotein E4 as the greatest known genetic risk factor for late-onset sporadic Alzheimer’s disease. Because APOE4 functions as an HDL-associated apolipoprotein, this genetic discovery provided a direct molecular bridge linking HDL biology to neurodegenerative mechanisms as well as cardiovascular health.

The authors’ review details how HDL and HDL-like particles actively influence several core classical hallmarks of Alzheimer’s disease pathophysiology. The synthesis evaluates growing experimental evidence connecting these lipoprotein particles to the accumulation and regulation of amyloid and tau pathology within the central nervous system.

Beyond protein aggregation and cellular inflammation, the review underscores the critical roles of HDL-like particles in maintaining cerebrovascular integrity, regulating local lipid metabolism, and preserving synaptic function.

Subject of Research: Roles of high-density lipoproteins in Alzheimer's disease pathophysiology and therapy

Article Title: HDL and Alzheimer’s disease: recent advances and therapeutic implications

Article References: Chang, A., Fredriksen, K., Joshi, S. S., Thieschafer, J., Kim, M., Bajgain, K., Roberts, A., & Li, L. (2026). HDL and Alzheimer’s disease: recent advances and therapeutic implications. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-026-01004-5

Image Credits: AI Generated

DOI: 10.1186/s13024-026-01004-5

Keywords: high-density lipoproteins, Alzheimer's disease, HDL function, HDL-like particles, apolipoprotein E4, APOE4, amyloid pathology, tau pathology, neuroinflammation, mitochondrial function, cerebrovascular integrity, lipid metabolism, synaptic function, HDL-targeted interventions, neurodegeneration, cardiovascular disease, soluble nanoparticles, Molecular Neurodegeneration

News Source: Cassandra Pierce. (November 17, 2026). Brain HDL Function Emerges as Key Factor in Alzheimer’s Disease Pathology. Scienmag.

Tags: Alzheimer's diseaseamyloid pathologyApoE4apolipoprotein E4Cardiovascular diseasecerebrovascular integrityHDL functionHDL-like particlesHDL-targeted interventionshigh-density lipoproteinslipid metabolismmitochondrial functionMolecular NeurodegenerationneurodegenerationNeuroinflammationsoluble nanoparticlessynaptic functionTau Pathology
Share12Tweet7Share2ShareShareShare1

Related Posts

Protocol Details Brazilian Portuguese Adaptation of Preterm Child Development Tool

Protocol Details Brazilian Portuguese Adaptation of Preterm Child Development Tool

November 17, 2026
Healthcare Algorithms Can Drive Patient Self-Doubt by Overriding Clinical Testimony

Healthcare Algorithms Can Drive Patient Self-Doubt by Overriding Clinical Testimony

November 17, 2026

Review Outlines How Specialized Nursing Care Improves Chest Pain Center Outcomes

November 17, 2026

Modified Posterior Sutureless Lens Fixation Secures Intraocular Implants in Large Series

November 17, 2026

POPULAR NEWS

  • Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

    29 shares
    Share 12 Tweet 7
  • Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

    29 shares
    Share 12 Tweet 7
  • Solvothermal Synthesis Yields Bismuth Selenide Nanoparticles with Distinct Phonon Modes

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Contrastive Graph Learning Framework Improves Spatial Domain Detection Across Tissue Platforms

Protocol Details Brazilian Portuguese Adaptation of Preterm Child Development Tool

Healthcare Algorithms Can Drive Patient Self-Doubt by Overriding Clinical Testimony

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.